|
Market Closed -
NYSE
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 2.880 USD | +13.83% |
|
+8.47% | -67.24% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MATINAS BIOPHARMA | - | +13.83% | +8.47% | -67.24% | -89.89% | -99.70% | 2.82M |  | | |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
